153 related articles for article (PubMed ID: 23807580)
1. New 7-[4-(4-(un)substituted)piperazine-1-carbonyl]- piperazin-1-yl] derivatives of fluoroquinolone: synthesis and antimicrobial evaluation.
Chen PT; Lin WP; Lee AR; Hu MK
Molecules; 2013 Jun; 18(7):7557-69. PubMed ID: 23807580
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-5-amino/methylaminopiperidin-1-yl)fluoroquinolone derivatives.
Zhang Y; Li G; Liu M; You X; Feng L; Lv K; Cao J; Guo H
Bioorg Med Chem Lett; 2011 Feb; 21(3):928-31. PubMed ID: 21232952
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-methyl-4-methylaminopiperidin-1-yl)-fluoroquinolone derivatives.
Zhang YB; Feng LS; You XF; Guo Q; Guo HY; Liu ML
Arch Pharm (Weinheim); 2010 Mar; 343(3):143-51. PubMed ID: 20186866
[TBL] [Abstract][Full Text] [Related]
4. N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation.
Asadipour A; Moshafi MH; Khosravani L; Moghimi S; Amou E; Firoozpour L; Ilbeigi G; Beiki K; Soleimani E; Foroumadi A
Daru; 2018 Dec; 26(2):199-207. PubMed ID: 30392156
[TBL] [Abstract][Full Text] [Related]
5. Moxifloxacin Derivatives with Potential Antibacterial Activity against Methicillin- Resistant Staphylococcus Aureus (MRSA).
Chen R; Xue H; Xu Y; Ma T; Liu Y; Zhang J; Shi X; Guo D
Curr Top Med Chem; 2021; 21(27):2474-2482. PubMed ID: 34645377
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-aminomethylpiperidin-1-yl)fluoroquinolone derivatives.
Chai Y; Wang J; Liu M; Yi H; Sun L; You X; Guo H
Bioorg Med Chem Lett; 2011 Jun; 21(11):3377-80. PubMed ID: 21515052
[TBL] [Abstract][Full Text] [Related]
7. JNJ-Q2, a new fluoroquinolone with potent in vitro activity against Staphylococcus aureus, including methicillin- and fluoroquinolone-resistant strains.
Farrell DJ; Liverman LC; Biedenbach DJ; Jones RN
Antimicrob Agents Chemother; 2011 Jul; 55(7):3631-4. PubMed ID: 21555765
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in-vitro antibacterial activity of 7-(3-aminopyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivatives.
Guo X; Bai XG; Li YL; An ZJ; Xu LX; Han LY; Liu ML; Guo HY; Wang YC
Arch Pharm (Weinheim); 2011 Aug; 344(8):523-9. PubMed ID: 21656543
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone.
Morrow BJ; He W; Amsler KM; Foleno BD; Macielag MJ; Lynch AS; Bush K
Antimicrob Agents Chemother; 2010 May; 54(5):1955-64. PubMed ID: 20176911
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a Novel Fluoroquinolone Antibiotic Candidate WFQ-228 with Potent Antimicrobial Activity and the Potential to Overcome Major Drug Resistance.
Hirano T; Kinoshita T; Kazamori D; Inoue S; Nishimura K; Sakurai A; Ohishi K; Kuramoto Y; Amano H; Yazaki A
Chem Pharm Bull (Tokyo); 2018 Mar; 66(3):235-238. PubMed ID: 29321384
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis and antibacterial activities of 7-{4-[2-[2-substituted-4-((5S)-5-acetylaminomethyl-2-oxo-oxazolidin-3-yl)}-phenyl] -ethyl]-piperazin-1-yl}-fluoroquinolones].
Yu HJ; Zhou WC
Yao Xue Xue Bao; 2006 Oct; 41(10):990-9. PubMed ID: 17184119
[TBL] [Abstract][Full Text] [Related]
12. Delafloxacin: A New Anti-methicillin-resistant Staphylococcus aureus Fluoroquinolone.
Saravolatz LD; Stein GE
Clin Infect Dis; 2019 Mar; 68(6):1058-1062. PubMed ID: 30060092
[TBL] [Abstract][Full Text] [Related]
13. Delafloxacin: a novel fluoroquinolone with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa.
Ocheretyaner ER; Park TE
Expert Rev Anti Infect Ther; 2018 Jul; 16(7):523-530. PubMed ID: 29911455
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A
Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668
[TBL] [Abstract][Full Text] [Related]
15. Studies on the antimicrobial properties of N-acylated ciprofloxacins.
Cormier R; Burda WN; Harrington L; Edlinger J; Kodigepalli KM; Thomas J; Kapolka R; Roma G; Anderson BE; Turos E; Shaw LN
Bioorg Med Chem Lett; 2012 Oct; 22(20):6513-20. PubMed ID: 22995622
[TBL] [Abstract][Full Text] [Related]
16. Allicin-inspired thiolated fluoroquinolones as antibacterials against ESKAPE pathogens.
Sheppard JG; Long TE
Bioorg Med Chem Lett; 2016 Nov; 26(22):5545-5549. PubMed ID: 27756563
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Evaluation of Thiazolidine Amide and N-Thiazolyl Amide Fluoroquinolone Derivatives.
Garza I; Wallace MJ; Fernando D; Singh A; Lee RE; Gerding JS; Franklin C; Yendapally R
Arch Pharm (Weinheim); 2017 Jun; 350(6):. PubMed ID: 28429393
[TBL] [Abstract][Full Text] [Related]
18. Terpene-Functionalized Fluoroquinolones as Potential Antimicrobials: Synthesis and Properties.
Izmest'ev ES; Pestova SV; Kolesnikova AI; Baidamshina DR; Kayumov AR; Rubtsova SA
ChemMedChem; 2023 Dec; 18(24):e202300358. PubMed ID: 37872856
[TBL] [Abstract][Full Text] [Related]
19. Discovery of the highly potent fluoroquinolone-based benzothiazolyl-4-thiazolidinone hybrids as antibacterials.
Patel RV; Park SW
Chem Biol Drug Des; 2014 Jul; 84(1):123-9. PubMed ID: 24524270
[TBL] [Abstract][Full Text] [Related]
20. Imidazolidine-4-one derivatives in the search for novel chemosensitizers of Staphylococcus aureus MRSA: synthesis, biological evaluation and molecular modeling studies.
Matys A; Podlewska S; Witek K; Witek J; Bojarski AJ; Schabikowski J; Otrębska-Machaj E; Latacz G; Szymańska E; Kieć-Kononowicz K; Molnar J; Amaral L; Handzlik J
Eur J Med Chem; 2015 Aug; 101():313-25. PubMed ID: 26160112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
